Recruiting

Cancer Prevention

Sponsor:

ClinLogic LLC

Code:

NCT03897374

Conditions

Early Detection of Cancer

Eligibility Criteria

Sex: All

Age: 65+

Healthy Volunteers: Not accepted

Interventions

Genetic Testing

Study Details

Brief summary:

The primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which may lead to early detection and treatment of the condition.

Conditions

Early Detection of Cancer

Study ID

NCT03897374

Start date

Mar 26, 2025

Status verified date

Mar, 2026

Completion date

Dec 31, 2028

Anticipated

Primary completion date

Dec 31, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 65+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Study subjects may be included in the Clinical Trial if they meet all of the following inclusion criteria:

  • individuals, ages 65 years or older;
  • must have met medical necessity for hereditary cancer genomic testing and allowed the physician to test based on medical necessity;
  • hereditary cancer diagnostic test was ordered by a physician related to individual subject care considerations.
  • study subject has or had cancer
  • study subject has at least one family member with cirrent or past cancer

Exclusion Criteria:

  • Study subjects will be excluded from the study if any of the following criteria apply: • study subject is currently hospitalized or incarcerated;

  • study subject is unable to provide an accurate history due to mental incapacity
  • study subject is currently abusing illicit and/or prescription drugs;

Study Design

Enrollment

120000 participants

Anticipated

Interventions and Outcome Measures

Interventions

Genetic Testing

Buccal swab

Primary outcome measure

  • Genomic cancer screen [ Time Frame: 120 Days ]
  • Genomic cancer screen [ Time Frame: 120 Days ]

Central Contacts and Locations

Central contacts

C David, MBA

7174671201stopcancer@callmdglobal.com

Locations

Sunbeam Clinical

Recruiting

Prosper, Texas, United States, 75078

More Information

Sponsor

ClinLogic LLC

Last update posted

Mar 19, 2026

Last verified

Mar, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by ClinLogic LLC on 2026-03-19.